Smart Blood Analytics Swiss has secured the European Medical Device Regulation (EU-MDR) certification for its VIRUS versus BACTERIA Clinical Decision Support Software.
The VIRUS versus BACTERIA software aims to address this issue by accurately distinguishing between viral and bacterial infections, enabling physicians to prescribe the most effective treatments.
With the widespread availability of routine blood testing, VIRUS versus BACTERIA can enhance the diagnostic capabilities of doctors globally, particularly in scenarios where other blood markers have limited diagnostic utility.
Smart Blood Analytics Swiss CEO Dr Marko Notar said: “This achievement shows our commitment to advancing healthcare through innovation.
With its certification, VIRUS versus BACTERIA is now poised to become a tool for healthcare professionals worldwide.
The software uses 17 routine blood parameters to differentiate infections. Credit: Khakimullin Aleksandr/Shutterstock.com.
Smart Blood Analytics Swiss has secured the European Medical Device Regulation (EU-MDR) certification for its VIRUS versus BACTERIA Clinical Decision Support Software.
This certification is a forward step in the fight against antimicrobial resistance (AMR), a growing global health concern.
AMR is exacerbated by the misuse and overuse of antibiotics. This not only threatens public health but also places a heavy financial burden on healthcare systems.
The VIRUS versus BACTERIA software aims to address this issue by accurately distinguishing between viral and bacterial infections, enabling physicians to prescribe the most effective treatments.
The software uses 17 routine blood parameters, biological sex, and age to differentiate infections.
Its effectiveness and accuracy were recently highlighted in a Heliyon journal article.
How well do you really know your competitors? Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge. View profiles in store Company Profile – free sample Thank you! Your download email will arrive shortly Not ready to buy yet? Download a free sample We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form By GlobalData Submit Country * UK USA Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Democratic Republic of the Congo Cook Islands Costa Rica Côte d"Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates US Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam British Virgin Islands US Virgin Islands Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Kosovo Industry * Academia & Education Aerospace, Defense & Security Agriculture Asset Management Automotive Banking & Payments Chemicals Construction Consumer Foodservice Government, trade bodies and NGOs Health & Fitness Hospitals & Healthcare HR, Staffing & Recruitment Insurance Investment Banking Legal Services Management Consulting Marketing & Advertising Media & Publishing Medical Devices Mining Oil & Gas Packaging Pharmaceuticals Power & Utilities Private Equity Real Estate Retail Sport Technology Telecom Transportation & Logistics Travel, Tourism & Hospitality Venture Capital Tick here to opt out of curated industry news, reports, and event updates from Medical Device Network. Submit and download Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
With the widespread availability of routine blood testing, VIRUS versus BACTERIA can enhance the diagnostic capabilities of doctors globally, particularly in scenarios where other blood markers have limited diagnostic utility.
Smart Blood Analytics Swiss CEO Dr Marko Notar said: “This achievement shows our commitment to advancing healthcare through innovation.
“By providing clinicians with a precise tool to differentiate between viral and bacterial infections, we aim to empower doctors with more information and help them in their decision of antibiotic prescriptions. This contributes to more effective healthcare practices.”
The inspiration for VIRUS versus BACTERIA came from the 2022 G20 Bali summit, which issued a call to action on AMR.
This summit underscored the critical need for innovative solutions to address the silent pandemic of AMR.
The EU-MDR certification process is rigorous, ensuring that medical devices meet very high standards of safety, quality, and compliance with EU regulations.
With its certification, VIRUS versus BACTERIA is now poised to become a tool for healthcare professionals worldwide.
Its user-friendly interface is designed to empower practitioners in their efforts to use antibiotics rationally and effectively to combat the threat of antimicrobial resistance.
